Plasma osteocalcin values and related hormonal parameters in patients subjected to a variety of prostate anticancer agents
Author:
- 1 February 1991
- journal article
- research article
- Published by Springer Nature in Urological Research
- Vol. 19 (1) , 39-44
Abstract
Circulating osteocalcin (OC) and cortisol levels were measured in blood samples from 93 patients with dissaminated prostate cancer. Among these subjects 79 had not responsed to therapy, while 14 had responded to a variety of anticancer treatment strategies (orchiectomy, cyproterone acetate (CPA), flutamide, Buserelin, diethylstilbestrol (DES), Estracyt, and polyestradiol phosphate). The control group consisted of 19 patients with benign prostatic hypertrophy. In the majority of these patients blood adrenocorticotropic hormone (ACTH), estradiol human growth hormone (hGH), and thyroid stimulating hormone (TSH) levels were also assessed. In nonresponders to therapy with DES and Estracyt subnormal circulating OC levels were measured, while normal OC values were found in nonresponders to other treatment strategies. In patient given Estracyt highly elevated estradiol levels were recorded. Subnormal and/or low-normal estradiol concentrations were found in patients subjected to CPA and DES. Elevated blood cortisol levels were assessed in subjects treated with DES and Estracyt while at the same time either subnormal and low-normal plasma ACTH concentrations were measured in these same patients. Accordingly, the decline observed in OC concentration seems to be a consequence of the well-established inhibitory effect of glucorticoids on osteoblast activity. The decline in blood cortisol levels obtained after administration of dexamethasone in patients given DES and Estracyt may be attributed both to possible changes in catabolic pathways and to the contribution of the negative neuroendocrinological feedback.Keywords
This publication has 23 references indexed in Scilit:
- Castrated Men Exhibit Bone Loss: Effect of Calcitonin Treatment on Biochemical Indices of Bone Remodeling*The Journal of Clinical Endocrinology & Metabolism, 1989
- Adrenocorticotropin-Independent Bilateral Macronodular Adrenal Hyperplasia: An Unusual Cause of Cushing’s Syndrome*The Journal of Clinical Endocrinology & Metabolism, 1989
- Effects of Estrogens and Calcium on Calcitonin Secretion in Postmenopausal Women*The Journal of Clinical Endocrinology & Metabolism, 1989
- Correlation between bone scans and serum levels of osteocalcin, prostate‐specific antigen, and prostatic acid phosphatase in monitoring patients with disseminated cancer of the prostateThe Prostate, 1989
- The Effect of Single Oral Doses of Prednisone on the Circadian Rhythm of Serum Osteocalcin in Normal Subjects*The Journal of Clinical Endocrinology & Metabolism, 1988
- Distribution and metabolism of estramustine in HeLa cells and the human prostatic tumour cell line 1013LBiochemical Pharmacology, 1988
- Evidence of Estrogen Receptors in Normal Human Osteoblast-Like CellsScience, 1988
- Osteocalcin Levels in Cushing's Disease before and after TreatmentHormone and Metabolic Research, 1988
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Serum osteocalcin (BGP) in tumor-associated hypercalcemiaJournal of Bone and Mineral Research, 1986